Creatinine tests diagnose impaired renal function & measure the amount of creatinine phosphate in the blood. BUN is an indirect & rough measurement of renal & live function measuring the amount of urea nitrogen in blood. BUN is directly related to the excretory function of the kidney.
This study investigated the association between serum creatinine and serum blood urea nitrogen levels with the presence of coronary artery disease.
Materials and Methods
The study was composed of 280 patients, between May 2011 and February 2012, were consecutively admitted at our institution due to symptoms related to CAD. All patients had elective coronary angiography at our centre. The patients were assessed a day prior to coronary angiography and a full clinical history was obtained. This study was designed as an observational prospective cohort study. Patients having angiographic evidence of stenosis in coronary artery or major branch segment in their epicardial coronary tree were as having CAD (Case group) and with out stenosis (Control group). Exclusion criteria were the first 4 weeks of acute coronary syndrome, previous percutaneous coronary intervention/stent implantation and/or previous coronary artery bypass grafting, presence of heart failure, alcohol consumption, patients with severely impaired renal function, neoplastic disease and chronic liver disease. Informed consent was obtained in accordance with the study protocol approved by the local ethical committee.
Coronary Angiography and Gensini Score:
Coronary angiography was performed from the percutaneous femoral approach using standard angiographic techniques. The presence and severity of CAD was determined by clinical vessel score. All coronary angiograms were evaluated by two experienced cardiologists who were blinded to the laboratory results of the patients. The severity of the each lesion was assessed by quantitative coronary angiography.
The presence and total severity of CAD was assessed according to Gensini scoring system. In this system, angiographic stenosis between 1% and 25% is scored as 1 point, 26% and 50% is scored as 2 points, between 51% and 75% is scored as 4 points, between 76% and 90% is scored as 8 points, between 91% and 99% is scored as 16 points and total occlusion is scored as 32 points. These scores are multiplied by the coefficient defined for each coronary artery and segment, and the results are then added. The presence of CAD has been defined as the Gensini score being >1.
Definitions of CAD Risk factors:
Analyzed risk factors of CAD were age, male sex, smoking, hyperlipidemia, diabetes, hypertension, family history of CAD and hyperuricemia. Hyperlipidemia was defined as plasma total cholesterol level >200 mg/dl, LDLcholesterol level >130mg/dl, triglyceride level >150mg/dl and HDL-cholesterol level <40 mg/dl or being on lipid lowering drugs at the time of the study. Patients were considered to have hypertension if they had received such a diagnosis with arterial pressure of more than 140/90mmHg or were being treated with antihypertensive medications. Patients were considered to have diabetes if they were taking insulin or oral hypoglycemic agents. Patients with a lack of awareness of their past history of diabetes were defined as a fasting blood glucose >120mg/dl. Patients with High creatinine concentration were defined as >1.2mg/dl or >105 µmol/L. Normal range are 0.9-1.2mg/dl or 80-105 µmol/L. Normal BUN levels of BUN are between 10-20 mg/dl.
Results:
Patients were allocated into two groups in terms of presence of CAD. Patients with Gensini scores >1were defined as the group with CAD and 134 patients were allocated in this group. Gensini score of 0 were classified as the group without CAD and 36 patients were included in this group. Demographic characteristics, the distribution of cardiovascular risk factors, Serum creatinine and serum blood urea nitrogen are presented in Table I .
Patients with or without CAD were similar in terms of age (45.22±6.80 years vs. 52.87±9.31 years, p<0.01) and significant age difference was found between patients. Gender difference was statistically significant (p<0.001). Smoking habit was significantly more frequent in patients with CAD (p=0.003) and statistically significant.
There was a statistically significant difference between the mean serum creatinine levels of patients with or without CAD (92.89±20.82 µmol/ L vs 108.68±23.62 µmol/L respectively (p<0.05). There was a statistically significant difference between serum blood urea nitrogen of patients with or without CAD (10.59±6.15 mg/dl vs. 20.37±6.73 respectively, p<0.01.
There was no significant difference between patients with or without CAD in terms of the total cholesterol, LDL-c, HDL-c and family history. The p values for continuous variables are taken from Mann-Whitney U test.
The univariate analysis of the variables are shown in Table I showing age, serum creatinine, ejection fraction, lipid profile and BUN among continuous variables, while age, serum creatinine, ejection fraction, TG and BUN, are significantly associated with coronary artery involvement.
While looking at the correlation coefficient of Gensini score with different factors, S. creatinine, ejection fraction and BUN were significantly correlated at<0.001 and <0.04 and <0.01 level respectively. Increased serum creatinine levels were found to be independent risk factors for the presence of CAD (for serum creatinine hazard ration 3.9, p<0.001 and in case BUN hazard ration 2.08, p<0.001). After getting the significant variables from univariate analysis, they were taken into the model of linear regression (Table II) to see their overall effects on Gensini score to learn that there is a significant overall effect (F=5.43, Table (III) . 
Discussion:
We had find that elevated serum creatinine and BUN on admission was associated with an increased burden of CAD on cardiac catheterization during index hospitalization in patients who presented with symptoms of unstable angina and without known cardiovascular disease. To the best of our knowledge, this study is the first to demonstrate this association. Furthermore, each 1 mg/dl increase in BUN was associated with an increased burden of CAD.
Blood urea nitrogen may have pro-athersclerotic effects, as uremia has been associated with an increased burden of oxidative stress. 10 BUN may also both inhibit nitric oxide synthesis and promote macrophage proliferation. 11 Specially, in vivo studies demonstrate that increasing levels of urea inhibt nitric oxide synthesis in mouse macrophages with concurrent macrophage proliferation. Furthermore, uremia accelerates atherosclerosis in Apolipoprotein E-deficient mice.
Other studies indicate that uremia induces the expression of osteoblast differentiation factor Cbfa1 in the intima and media of arteries, which may lead to vascular calcification. 12 Elevated creatinine and BUN may also serve as a marker of an activated sympathetic nervous system and/ or an up regulated rennin-angiotensin system, reported promotes of atherosclerosis. 13 Activation of these neurohormonal systems has been associated with increased BUN reabsorption in the renal tubules.
We observed this association between increased creatinine and BUN with CAD while correcting for creatinine clearance. Concurrent reports show that increasing BUN predicts poor outcome in subjects with acute coronary syndromes despite normal or mildly reduced glomerular filtration rates. Consequently, an elevated serum creatinine and BUN may represent an independent marker of renal dysfunction, which would further support the well established association between renal disease and CAD. 14 However, additional study is required to evaluate this point.
Limitations:
Our study was observational in nature, which possibly restricted us in identifying and analyzing all potential confounding factors. The serum creatinine and BUN levels were a single measurement are not necessarily a reflection of one's chronic levels. Serum creatinine and BUN elevation may occur for reasons other than neurohormonal up-regulation and/or the presence of renal dysfunction. Analysis was based on a single measurement of creatinine and BUN the changes in levels over time are likely to occur. The main limitation that needs to be acknowledged regarding this study is the possible and unknown effects of the ongoing medications including diuretics.
Conclusion:
In conclusion, a significant association has been found between serum creatinine and BUN level with the presence of CAD. In addition to the evaluation of conventional risk factors in daily clinical practice, the measurement of creatinine and BUN level might provide significant prognostic benefits in terms of global cardiovascular risk and management of the patients. Further study is warranted to explore this association.
